{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:02:53Z","timestamp":1779721373604,"version":"3.53.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"am","delay-in-days":223,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2 P20 GM121312"],"award-info":[{"award-number":["2 P20 GM121312"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA050989"],"award-info":[{"award-number":["U01DA050989"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001380","name":"The William K Warren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U01MD017867"],"award-info":[{"award-number":["U01MD017867"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jad.2025.119858","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:39:50Z","timestamp":1752579590000},"page":"119858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Treatment resistant depression: Socio-demographic characteristics, comorbidity and treatment patterns from the All of Us Research Program"],"prefix":"10.1016","volume":"390","author":[{"given":"Katherine L.","family":"Forthman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayus","family":"Kuplicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley K.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Chieh","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119858_bb0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \"all of us\" research program","volume":"381","author":"All of Us Research Program, I","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.119858_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.09.033","article-title":"Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study","volume":"189","author":"Balestri","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0015","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/add.14596","article-title":"Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study","volume":"114","author":"Brenner","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2025.119858_bb0020","article-title":"Clinical and biological factors are associated with treatment-resistant depression","volume":"12","author":"Buoli","year":"2022","journal-title":"Behav. Sci. (Basel, Switzerl.)"},{"key":"10.1016\/j.jad.2025.119858_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/da.22774","article-title":"Finding factors that predict treatment-resistant depression: results of a cohort study","volume":"35","author":"Cepeda","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2025.119858_bb0030","article-title":"Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort study","volume":"22","author":"Chan","year":"2022","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.jad.2025.119858_bb0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatr. (Chicago, Ill.)"},{"key":"10.1016\/j.jad.2025.119858_bb0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","article-title":"Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial","volume":"78","author":"Deligiannidis","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/03007995.2020.1857580","article-title":"A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom","volume":"37","author":"Denee","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2025.119858_bb0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/15622975.2020.1851052","article-title":"A clinical approach to treatment resistance in depressed patients: what to do when the usual treatments don\u2019t work well enough?","volume":"22","author":"Dodd","year":"2021","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ijnp\/pyy024","article-title":"The genetics of treatment-resistant depression: a critical review and future perspectives","volume":"22","author":"Fabbri","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119858_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2025.119858_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","article-title":"A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method","volume":"70","author":"Fekadu","year":"2009","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0070","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14345","article-title":"Efficacy and safety of AXS-05 (dextromethorphan-bupropion) in patients with major depressive disorder: a phase 3 randomized clinical trial (GEMINI)","volume":"83","author":"Iosifescu","year":"2022","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","article-title":"The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature","volume":"242","author":"Johnston","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0080","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.20230247","article-title":"Genome-wide association study of treatment-resistant depression: shared biology with metabolic traits","volume":"181","author":"Kang","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119858_bb0085","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11385","article-title":"Refining prediction in treatment-resistant depression: results of machine learning analyses in the TRD III sample","volume":"79","author":"Kautzky","year":"2018","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/acps.12959","article-title":"Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study","volume":"139","author":"Kautzky","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.119858_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nn.3275","article-title":"Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions","volume":"16","author":"Klengel","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jad.2025.119858_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076882","article-title":"Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database","volume":"8","author":"Kubitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2025.119858_bb0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41398-020-01035-6","article-title":"Genome-wide association studies of antidepressant class response and treatment-resistant depression","volume":"10","author":"Li","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.119858_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2022.3860","article-title":"Association of treatment-resistant depression with patient outcomes and health care resource utilization in a population-wide study","volume":"80","author":"Lundberg","year":"2023","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/wps.20771","article-title":"The clinical characterization of the adult patient with depression aimed at personalization of management","volume":"19","author":"Maj","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2025.119858_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1291176","article-title":"Biological correlates of treatment resistant depression: a review of peripheral biomarkers","volume":"14","author":"Mancuso","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2020.02.023","article-title":"The identification, assessment and management of difficult-to-treat depression: an international consensus statement","volume":"267","author":"McAllister-Williams","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2025.119858_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2022.02.015","article-title":"The potential of polygenic risk scores to predict antidepressant treatment response in major depression: a systematic review","volume":"304","author":"Meerman","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"Suppl","key":"10.1016\/j.jad.2025.119858_bb0140","first-page":"39","article-title":"Treatment-resistant depression: definition and treatment approaches","volume":"51","author":"Nierenberg","year":"1990","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253023","article-title":"Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1","volume":"16","author":"Nunez","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2025.119858_bb0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jad.2017.11.004","article-title":"Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression","volume":"227","author":"Olgiati","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0155","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1080\/03007995.2022.2113692","article-title":"Observational study to characterize treatment-resistant depression in Germany, France and the United Kingdom: analysis of real-world data collected through a survey of healthcare professionals","volume":"38","author":"Orsini","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2025.119858_bb0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41386-023-01751-9","article-title":"Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study","volume":"49","author":"Parikh","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.119858_bb0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jad.2016.08.019","article-title":"The Dutch measure for quantification of treatment resistance in depression (DM-TRD): an extension of the Maudsley staging method","volume":"205","author":"Peeters","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0170","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jad.2021.08.036","article-title":"Economic impact of treatment-resistant depression: A retrospective observational study","volume":"295","author":"Perez-Sola","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0175","series-title":"The Precision Medicine Initiative Cohort Program \u2013 Building a Research Foundation for 21 st Century Medicine, Washington, DC","first-page":"1","author":"Precision Medicine Initiative (PMI) Working Group Report to the Advisory Committee to the Director, N","year":"2015"},{"key":"10.1016\/j.jad.2025.119858_bb0180","series-title":"R: A Language and Environment for Statistical Computing. (Version 4.4.2)","author":"R Core Team","year":"2025"},{"key":"10.1016\/j.jad.2025.119858_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.925879","article-title":"Sigma-1 receptors in depression: mechanism and therapeutic development","volume":"13","author":"Ren","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2025.119858_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0004867418808585","article-title":"Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive","volume":"53","author":"Rush","year":"2019","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0195","doi-asserted-by":"crossref","first-page":"7262794","DOI":"10.1155\/2024\/7262794","article-title":"Use of Esketamine nasal spray in patients with treatment-resistant depression in routine practice: a real-world French study","volume":"2024","author":"Samalin","year":"2024","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2025.119858_bb0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/0269881111431748","article-title":"The hidden third: improving outcome in treatment-resistant depression","volume":"26","author":"Schlaepfer","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119858_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamainternmed.2023.6300","article-title":"Population weighting in statistical analysis","volume":"184","author":"Si","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jad.2025.119858_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119858_bb0215","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2021.04.074","article-title":"Predicting clinical outcome to specialist multimodal inpatient treatment in patients with treatment resistant depression","volume":"291","author":"Taylor","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 13","key":"10.1016\/j.jad.2025.119858_bb0220","first-page":"23","article-title":"When at first you don\u2019t succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0225","first-page":"1","article-title":"Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression","volume":"12","author":"Trivedi","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.119858_bb0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jad.2013.06.037","article-title":"The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression","volume":"152-154","author":"Tunnard","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119858_bb0235","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/ph16111572","article-title":"Pharmacotherapies targeting GABA-glutamate neurotransmission for treatment-resistant depression","volume":"16","author":"Vecera","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jad.2025.119858_bb0240","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2024.4825","article-title":"Genetic correlates of treatment-resistant depression","author":"Xu","year":"2025","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jad.2025.119858_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2013.12.003","article-title":"Epigenetics and the regulation of stress vulnerability and resilience","volume":"264","author":"Zannas","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2025.119858_bb0250","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.119858_bb0255","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1007\/s12325-021-01862-z","article-title":"Prevalence of pre-existing conditions relevant for adverse events and potential drug-drug interactions associated with augmentation therapies among patients with treatment-resistant depression","volume":"38","author":"Zhdanava","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jad.2025.119858_bb0260","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatr."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272501300X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272501300X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:09:46Z","timestamp":1779718186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272501300X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S016503272501300X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119858","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment resistant depression: Socio-demographic characteristics, comorbidity and treatment patterns from the All of Us Research Program","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119858"}}